(HHH) HSBC SP500 - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: IE00B5KQNG97 • US Large-Cap Blend Equity
HHH: Equity, Stocks, Shares, Investments, Funds
HSBC S&P 500 UCITS ETF (Ticker: HHH, Exchange: PA) is an exchange-traded fund designed to track the performance of the S&P 500 Index, a widely recognized benchmark for large-cap U.S. equities. Domiciled in Ireland, this fund is structured as a UCITS-compliant ETF, making it accessible to investors across Europe and beyond. The ETF is managed by HSBC Asset Management, a global investment manager with a strong track record in passive strategies.
With assets under management (AUM) of approximately €7.67 billion, this ETF is one of the larger funds in its category. It focuses on replicating the returns of the S&P 500 Index, which includes 500 of the largest and most liquid U.S. companies. The fund employs a full replication strategy, meaning it holds all or a representative sample of the constituents of the index to minimize tracking error. The expense ratio is competitive, aligning with the broader trend of cost-efficient passive investment vehicles.
Investors in HHH gain exposure to a diversified portfolio of U.S. large-cap equities, spanning sectors such as technology, healthcare, financials, and consumer goods. The fund is denominated in EUR, which means returns are converted from USD to EUR, and currency fluctuations can impact performance. This ETF is suitable for investors seeking long-term growth, capital appreciation, and diversification within their portfolios.
From a trading perspective, HHH is listed on Euronext Paris (PA), offering European investors easy access and liquidity. The fund is structured to be tax-efficient for European investors, as it complies with UCITS regulations. HSBC Asset Management has a robust infrastructure to support this ETF, including robust risk management and regular disclosures to ensure transparency.
Additional Sources for HHH ETF
HHH ETF Overview
Market Cap in USD | 8,303m |
Category | US Large-Cap Blend Equity |
TER | 0.09% |
IPO / Inception | 2010-05-14 |
HHH ETF Ratings
Growth 5y | 89.5% |
Fundamental | - |
Dividend | 53.8% |
Rel. Strength | -0.38 |
Analysts | - |
Fair Price Momentum | 51.57 EUR |
Fair Price DCF | - |
HHH Dividends
Dividend Yield 12m | 1.10% |
Yield on Cost 5y | 2.57% |
Annual Growth 5y | 4.58% |
Payout Consistency | 99.0% |
HHH Growth Ratios
Growth Correlation 3m | -55.7% |
Growth Correlation 12m | 85.5% |
Growth Correlation 5y | 92.7% |
CAGR 5y | 18.07% |
CAGR/Max DD 5y | 1.05 |
Sharpe Ratio 12m | 1.29 |
Alpha | 4.51 |
Beta | 0.000 |
Volatility | 16.46% |
Current Volume | 35.1k |
Average Volume 20d | 14.5k |
As of March 31, 2025, the stock is trading at EUR 52.13 with a total of 35,109 shares traded.
Over the past week, the price has changed by -3.17%, over one month by -9.71%, over three months by -9.08% and over the past year by +8.05%.
Yes. Based on ValueRay Analyses, HSBC SP500 (PA:HHH) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 89.46 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HHH as of March 2025 is 51.57. This means that HHH is currently overvalued and has a potential downside of -1.07%.
HSBC SP500 has no consensus analysts rating.
According to ValueRays Forecast Model, HHH HSBC SP500 will be worth about 57.2 in March 2026. The stock is currently trading at 52.13. This means that the stock has a potential upside of +9.67%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 57.2 | 9.7% |